Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 464 a 483 di 503
Titolo Data di pubblicazione Autore(i) File
THE INHIBITION OF IKK KINASE IS ABLE TO INDUCE GROWTH ARREST AND APOPTOSIS IN AML BLAST CELLS 2005 F. Messa; F. Arruga; I. Defilippi; A. Morotti; M. Pautasso; E. Messa; E. Giugliano; V. Rosso; E. Gottardi; G. Saglio; D. Cilloni
The kinetic features of human acute leukaemia as a guide to its chemotherapeutic management. 1977 MASERA P ;MATERA L ;GAVOSTO F
THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES 2009 M. Coscia;1 F. Pantaleoni; C. Riganti; M. Rigoni; S. Peola; C. Vitale; D. Drandi; M. Ladetto; A. Bosia; M. Boccadoro; M. Massaia
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML WorkingParty experience after a 7-year follow-up 2009 Palandri F; Castagnetti F; Alimena G; Testoni N; Breccia M; Luatti S; Rege-Cambrin G; Stagno F; Specchia G; Martino B; Levato L; Merante S; Liberati AM; Pane F; Saglio G; Alberti D; Martinelli G; Baccarani M; Rosti G.
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL) 2012 Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party 2010 Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G.
The prognostic value of bone involvement in childhood acute lymphoblastic leukaemia (author's transl) 1981 Pastore G; Miniero R; Cordero di Montezemolo L; Felicioni V; Fiandino G; Grazia G; Morgando MP; Trada M; Madon E.
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase 2010 Palandri F; Castagnetti F; Iacobucci I; Martinelli G; Amabile M; Gugliotta G; Poerio A; Testoni N; Breccia M; Bocchia M; Crugnola M; Rege-Cambrin G; Martino B; Pierri I; Radaelli F; Specchia G; Pane F; Saglio G; Rosti G; Baccarani M.
The role of BCR/ABL isoforms in the presentation and outcome of patients withPhiladelphia-positive acute lymphoblastic leukemia: a seven-year update of theGIMEMA 0496 trial. 2006 Cimino G; Pane F; Elia L; Finolezzi E; Fazi P; Annino L; Meloni G; Mancini M; Tedeschi A; Di Raimondo F; Specchia G; Fioritoni G; Leoni P; Cuneo A; Mecucci C; Saglio G; Mandelli F; Foà R; GIMEMA Leukemia Working Party
THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT 2009 Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
The unbalanced ratio between KTS- and KTS+ isoforms of WT1 may probably be responsible for the dysfunction of its physiological role in leukemic cells 2005 Defilippi I; Messa F; Arruga F; Serra A; Rosso V; Catalano R; Reviglione R; Morotti A; Messa E; Carturan S; Gottardi E; Bracco E; Saglio G; Cilloni D
The use of differentiated regimens in therapy of children with acute lymphoblastic leukemia 1983 Madon E; Pastore G; Cordero Di Montezemolo L; Grazia G; Brach Del Prever A.
Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors 2001 IOLASCON A;GIORDANO P;STORELLI S;LI HH;COPPOLA B;PIGA A;FANTOLA E;FORNI G;CIANCIULLI P;PERROTTA S;MAGNANO C;MAGGIO A;MANGIAGLI A;DEVOTO M
Thrombophilic mutations are a main risk factor for placental abruption. 2003 Facchinetti F; Marozio L; Grandone E; Pizzi C; Volpe A; Benedetto C.
THROMBOPROPHYLAXIS FOR NEWLY DIAGNOSED MULTIPLEMYELOMA PATIENTS TREATED WITH LENALIDOMIDE-BASEDREGIMENS: A RANDOMIZED PHASE III STUDY OF ASPIRINVS ENOXAPARIN 2011 A Larocca; F Cavallo; A Evangelista; F Di Raimondo; L Catalano; M Galli; C Cangialosi; G Benevolo; D Rossi; T Guglielmelli; L Masini;F Rossi; R Ria; N Cascavilla; N Pescosta;A Baraldi; M Marcatti; T Caravita Di Toritto;A Nagler;M Boccadoro; A Palumbo
THYMIC OUTPUT AND T CELL RECONSTITUTION FOLLOWING NON-MYELOABLATIVE ALLOGRAFTING 2008 Bruno B; Sfiligoi C; Omedè P; Cena S; Spagnolo M; Testa C; Cimolin L; Resta I; Sorasio R; Resta I; Giaccone L; Boccadoro M
Total body irradiation: Recent radiobiological and technological acquisitions [Irradiazione corporea totale: Recenti acquisizioni radiobiologiche e tecnologiche] 2008 Corvò; R.; Barra; S.; Filippi; A.; Ricardi; U.
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation 2010 M. Poli;S. Luscieti;V. Gandini;F. Maccarinelli;D. Finazzi;L. Silvestri;A. Roetto;P. Arosio
Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes 2005 REGE-CAMBRIN, G; Giugliano, E; Michaux, L; Stul, M; Scaravaglio, P; Serra, A; Saglio, G; Hagemeijer, A.
The tryptophan metabolism in the immune dysregulation of multiple myeloma 2007 Fiore F, Castella B, Assalto C, Zappia S, Hwang SY, Vitale C, Boccadoro M, Massaia M
Mostrati risultati da 464 a 483 di 503
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile